01/10/2025
3:26 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:33 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:40 AM | Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/08/2024
3:20 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
6:22 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:00 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
09/16/2024
5:46 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
12:49 PM | Immunocore (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SC 13G | |
08/29/2024
6:21 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:21 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:06 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/30/2024
4:22 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
3:43 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2024
3:46 PM | Immunocore (Issuer)
KRISHANA RANJEEV (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2024
3:17 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:15 PM | Bell John Irving (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Herbst Roy Steven (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Immunocore (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:50 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:13 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:00 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
3:34 PM | Immunocore (Filer)
| Form ARS | |
04/05/2024
3:35 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:34 PM | Immunocore (Filer)
| Form 424B7 | |
04/02/2024
3:45 PM | Immunocore (Filer)
| Form PRE 14A | |
04/01/2024
11:36 AM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
7:51 PM | Immunocore (Filer)
| Form S-3ASR | |
03/20/2024
7:55 PM | Immunocore (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Immunocore (Subject)
| Form SC 13G | |
03/07/2024
8:45 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
02/28/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:19 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:33 AM | Immunocore (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
5:46 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:15 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:16 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/14/2024
6:57 AM | Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/06/2024
10:00 AM | Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/01/2024
4:25 PM | BAKER BROS. ADVISORS LP (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
